Krystal Biotech Inc (KRYS)
177.39
-6.83
(-3.71%)
USD |
NASDAQ |
Nov 14, 16:00
177.41
+0.02
(+0.01%)
After-Hours: 20:00
Krystal Biotech Cash and Short Term Investments (Quarterly): 588.32M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 588.32M |
| June 30, 2024 | 559.61M |
| March 31, 2024 | 538.26M |
| December 31, 2023 | 532.18M |
| September 30, 2023 | 562.07M |
| June 30, 2023 | 477.52M |
| March 31, 2023 | 350.39M |
| December 31, 2022 | 379.17M |
| September 30, 2022 | 394.42M |
| June 30, 2022 | 425.56M |
| March 31, 2022 | 434.63M |
| December 31, 2021 | 438.10M |
| September 30, 2021 | 343.09M |
| June 30, 2021 | 367.73M |
| March 31, 2021 | 403.42M |
| December 31, 2020 | 271.26M |
| Date | Value |
|---|---|
| September 30, 2020 | 286.36M |
| June 30, 2020 | 297.17M |
| March 31, 2020 | 186.70M |
| December 31, 2019 | 193.68M |
| September 30, 2019 | 203.21M |
| June 30, 2019 | 195.47M |
| March 31, 2019 | 106.63M |
| December 31, 2018 | 111.76M |
| September 30, 2018 | 52.29M |
| June 30, 2018 | 45.45M |
| March 31, 2018 | 47.23M |
| December 31, 2017 | 49.59M |
| September 30, 2017 | 52.57M |
| June 30, 2017 | 3.518M |
| December 31, 2016 | 1.923M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
186.70M
Minimum
Mar 2020
588.32M
Maximum
Sep 2024
401.48M
Average
398.92M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Bioventus Inc | 43.07M |
| ADMA Biologics Inc | 86.71M |
| Alnylam Pharmaceuticals Inc | 2.780B |
| Amicus Therapeutics Inc | 249.76M |
| Apellis Pharmaceuticals Inc | 396.86M |